Ionis will receive $280M upfront from Ono, with potential milestone payments of up to $660M and mid-teen percentage royalties on net sales. Sapablursen, an investigational RNA therapy for ...
Van ECK Associates Corp’s holdings in Ionis Pharmaceuticals were worth $2,154,000 as of its most recent filing with the Securities and Exchange Commission. Other hedge funds also recently added ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback